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EMERGING INFECTIONS AND 
ZOONOSES
• EMERGING INFECTIONS: A COLLECTIVE 
NAME FOR INFECTIOUS DISEASES THAT 
HAVE BEEN IDENTIFIED AND 
TAXONOMICALLY CLASSIFIED RECENTLY; 
IN HUMANS, IN THE FINAL QUARTER OF THE 
TWENTIETH CENTURY, MORE THAN 30 
SUCH CONDITIONS WERE RECOGNISED
• SEVENTY TO SEVENTY FIVE % OF  NEW 
EMERGING INFECTIONS IN HUMANS ARE 
ZOONOTIC (WILDLIFE)
ZOONOSES
A LARGE NUMBER OF HUMAN 
PATHOGENS (61% OF THE 1,415 
IDENTIFIED HUMAN PATHOGENS 
BELONGING TO 313 DIFFERENT 
GENERA) ARE ZOONOTIC AND 
INFECT MULTIPLE ANIMAL SPECIES
BIODIVERSITY
• VIRUSES: ROUGHLY 5,000 KNOWN SPECIES; 
ESTIMATED NUMBER OF SPECIES: 130,000; 
PERCENTAGE OF KNOWN SPECIES: 4%
• BACTERIA: ROUGHLY 4,700 KNOWN 
SPECIES; ESTIMATED NUMBER OF 
SPECIES: 40,000; PERCENTAGE OF KNOWN 
SPECIES: 12%
• MAMMALS: 5,416 KNOWN SPECIES; 
ESTIMATED NUMBER OF SPECIES: 5,500; 
PERCENTAGE OF KNOWN SPECIES: 99%
MAMMAL SPECIES
• THE INVENTORY OF MAMMAL SPECIES IN 
1982 CONTAINED 4,170 SPECIES; THE 
INVENTORY IN 1993 CONTAINED 4,629 
SPECIES, AS COMPARED TO 5,416 IN 2005
• MOST OF THE INCREASE IN NUMBER IS 
DUE TO TAXONOMIC (GENOTYPIC) 
REVISION, BUT A SIGNIFICANT 
PROPORTION IS DUE TO NEWLY 
DESCRIBED SPECIES 
ORDER CHIROPTERA
• AMONG MAMMAL SPECIES, THERE 
ARE 1,116 BAT SPECIES BELONGING 
TO 202 GENERA; 49 NEW SPECIES 
HAVE BEEN RECOGNISED SINCE 1993
• THAT IS TO SAY, 20.6% OF THE TOTAL 
NUMBER OF MAMMAL SPECIES

ORDER RODENTIA
• AMONG MAMMAL SPECIES, THERE 
ARE 2,277 RODENT SPECIES 
BELONGING TO 481 GENERA; 128 NEW 
SPECIES HAVE BEEN RECOGNISED 
SINCE 1993
• THAT IS TO SAY, 42% OF THE TOTAL 
NUMBER OF MAMMAL SPECIES
WILD MAMMAL BIODIVERSITY
THE HOTSPOTS OF MAMMAL 
BIODIVERSITY ARE OBSERVED IN 
TROPICAL AREAS, SUCH AS SUB-
SAHARAN AFRICA, INDONESIA AND 
SOUTH AMERICA 

BIODIVERSITY OF DOMESTIC 
MAMMALS
• THERE ARE MORE THAN 300 RECOGNISED DOG 
BREEDS WITH DIFFERENT GENETIC 
BACKGROUNDS
• THERE ARE APPROXIMATELY 700 CATTLE BREEDS 
THROUGHOUT THE WORLD, MANY OF WHICH ARE 
AT A CRITICAL STAGE  (LESS THAN 100 BREEDING 
COWS; GENETIC DIVERSITY EROSION)
• DOMESTIC BREEDS DIFFER IN THEIR 
SUSCEPTIBILITY TO INFECTIONS AND THEIR 
IMMUNE RESPONSE AFTER INFECTION 
MECHANISMS OF EMERGENCE
MAMMALS AND VIRUSES
• VIRUS MUTATION (CANINE 
PARVOVIRUS INFECTION)
• OPENING THE ECOSYSTEMS
• CLIMATIC CHANGES
• INVASIVE SPECIES
• INTRODUCTION OF NEW SPECIES 









WHY SHOULD WE DEVELOP 
VETERINARY VACCINES?
• To protect animal health
• To improve animal welfare
• To protect public health
• To protect consumers of products derived from 
food- producing animals
• To protect the environment and biodiversity
• To avoid methane emission
• To promote sustainable agriculture and animal 
production
• To avoid the emergence of pathogens resistant to 
available drugs
OBSTACLES TO VETERINARY 
VACCINE DEVELOPMENT
• Products specific for one condition, often in a single 
species
• Scientific obstacles (e.g. African swine fever, many anti-
parasitic vaccines)
• Poor investment return for the companies involved in 
vaccine development and production
• The existence of so-called ( minor ) target species
• The existence of conditions of minor importance in so-
called ( major ) species
• The existence of conditions of minor importance in so-
called ( minor ) species (the worst-case scenario)
• Lack of uniformity in the geographic distribution of food-
producing animals
• The existence of vaccination bans due to animal health 
regulations
• Regulatory requirements for vaccine registration






• SEVEN SEROTYPES FURTHER 
DIVIDED INTO NUMEROUS SUB-TYPES
• A PURIFIED VACCINE
• A COMPANION DIAGNOSTIC TEST 
BASED ON ANTIBODY DETECTION 
AGAINST NON-STRUCTURAL 
PROTEINS
• CERTIFICATION AT HERD LEVEL
• DETECTION OF CARRIERS?  


• Muzzle: ulcerous 
and necrotic 
lesions, scabs





• Oral cavity: 
ulcers in the 









Clinical bluetongue in cattle: face
BLUETONGUE
• TWENTY-FOUR SEROTYPES
• TRANSMISSION BY BITING MIDGES 
(Culicoides) 
• THE BEST WAY TO CONTROL IT, IS 
VACCINATION OF LIVESTOCK
• ATTENUATED OR INACTIVATED VACCINES
• TWO YEARS WERE NEEDED FOR THE 
AVAILABILITY OF AN INACTIVATED VACCINE 
AGAINST SEROTYPE 8
WEST NILE VIRUS INFECTION IN 
UNITED-STATES OF AMERICA 
AND CANADA
• BIRDS AS WILDLIFE RESERVOIR
• TRANSMITTED BY MOSQUITOES
• INFECTING HUMANS AND HORSES
• INCREDIBLY RAPID SPREAD
• VACCINES QUICKLY AVAILABLE FOR 
HORSES, INCLUDING A DNA VACCINE
RIFT VALLEY FEVER
• EXPANDING ITS RANGE IN AFRICA
• RECENT INTRODUCTION IN MADAGASCAR
• TRANSMITTED BY MOSQUITOES
• INFECTING LIVESTOCK, WILD ANIMALS AND 
HUMANS
• AN ATTENUATED VACCINE AVAILABLE FOR 
SHEEP
• THIS VACCINE IS ABORTIGENIC 
STOCKPILING
• STOCKPILING OF CONCENTRATED 
PURIFIED ANTIGENS OF FOOT-AND-
MOUTH DISEASE VIRUS
• STOCKPILING TO MITIGATE THE RISK 
OF BIO-AGRO-TERRORISM
• STOCKPILING OF H5N1 INFLUENZA 
VACCINES FOR HUMANS ?
HIGHLY PATHOGENIC AVIAN 
INFLUENZA
FOR THE TIME BEING THE BEST IS TO 
TRY TO CONTROL THE INFECTION AT 
THE AVIAN SOURCE, NOTABLY 
THROUGH VACCINATION,IN ORDER 
TO MINIMIZE THE RISK OF MUTATION, 
THE RISK OF TRANSMISSION TO 




WILDLIFE VACCINATION AGAINST 
RABIES IS A GOOD EXAMPLE OF 
CONTROL AT THE SOURCE.













CONTROL OF FOOD POISONING
• PREVENTION OF ANIMAL CARCASS 
CONTAMINATION BY VACCINATION 
AGAINST SALMONELLA INFECTION
• VACCINATION OF CATTLE AGAINST 
Escherichia coli 0157:H7 IN USA
• PREVENTION OF  CYSTICERCOSIS
IN CATTLE AND PIGS 
THE NEW CHALLENGES TO 
FACE
• Vaccination against new and emerging diseases
• Bio-and-Agro-terrorism
• Adaptation to ever changing pathogens
• Consumer’s attitude towards animal vaccination
• Globalisation of trade (the 5ts and 
transboundary diseases)
• Harmonisation of international regulations
• Vaccination and animal diseases eradication
• Animal vaccination and public health

